The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
Open accessAbstract
Heart failure in humans is characterized by alterations in myocardial adrenergic signal transduction, the most prominent of which is down-regulation of beta 1-adrenergic receptors. We tested the hypothesis that down-regulation of beta 1-adrenergic receptors in the failing human heart is related to decreased steady-state levels of beta 1 receptor mRNA. Due to the extremely low abundance of beta 1 receptor mRNA, measurements were possible only by quantitative polymerase chain reaction (QPCR) or by RNase protection methods. Because the beta 1 receptor gene is intronless and beta 1 receptor mRNA abundance is low, QPCR yielded genomic amplification in total RNA, and mRNA measurements had to be performed in poly (A)(+)-enriched RNA. By QPCR the concentration of beta 1 receptor mRNA varied from 0.34 to 7.8 x 10(7) molecules/microgram poly(A)(+)-enriched RNA, and the assay was sensitive to 16.7 zeptomol. Using 100-mg aliquots of left ventricular myocardium obtained from organ donors (nonfailing ventricles, n = 12) or heart transplant recipients (failing ventricles, n = 13), the respective beta 1 mRNA levels measured by QPCR were 4.2 +/- 0.7 x 10(7)/micrograms vs. 2.10 +/- 0.3 x 10(7)/micrograms (P = 0.006). In these same nonfailing and failing left ventricles the respective beta 1-adrenergic receptor densities were 67.9 +/- 6.9 fmol/mg vs. 29.6 +/- 3.5 fmol/mg (P = 0.0001). Decreased mRNA abundance in the failing ventricles was confirmed by RNase protection assays in total RNA, which also demonstrated a 50% reduction in beta 1 message abundance. We conclude that down-regulation of beta 1 receptor mRNA contributes to down-regulation of beta 1 adrenergic receptors in the failing human heart.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[67] A molecular titration assay to measure transcript prevalence levels
Lee, J. J., & Costlow, N. A. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)52070-5 · Cited by 149
Cited by
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.186093 · Cited by 1,030
“For example, the development of techniques for quantifying gene expression in small amounts of EMB tissue using PCR (149) led to the finding that recapitulation of the “fetal gene program” that accompanied the development of heart failure could be reversed with normalization of left ventricular function (150) and that…”
MethodSelf-citationAdrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.008 · Cited by 672
Self-citationLowes, B. D., Minobe, W., Abraham, W. T., Rizeq, M. N., Bohlmeyer, T. J., Quaife, R. A., Roden, R. L., Dutcher, D. L., Robertson, A. D., Voelkel, N. F., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119770 · Cited by 503
Self-citationEichhorn, E. J., & Bristow, M. R. (1996) · Circulation · doi:10.1161/01.cir.94.9.2285 · Cited by 468
Self-citationCooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm456 · Cited by 464
Self-citationAnimal models of human cardiovascular disease, heart failure and hypertrophy
Hasenfuss, G. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00110-2 · Cited by 441
Myosin heavy chain gene expression in human heart failure.
Nakao, K., Minobe, W., Roden, R., Bristow, M. R., & Leinwand, L. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119776 · Cited by 413
Self-citationMoniotte, S., Kobzik, L., Feron, O., Trochu, J.-N., Gauthier, C., & Balligand, J.-L. (2001) · Circulation · doi:10.1161/01.cir.103.12.1649 · Cited by 328
Altered Beta-adrenergic Receptor Gene Regulation and Signaling in Chronic Heart Failure
Port, J. D., & Bristow, M. R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1358 · Cited by 280
Self-citationDilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A
Antos, C. L., Frey, N., Marx, S. O., Reiken, S., Gaburjakova, M., Richardson, J. A., Marks, A. R., & Olson, E. N. (2001) · Circulation Research · doi:10.1161/hh2301.100003 · Cited by 278
Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic Mice
Bisognano, J. D., Weinberger, H. D., Bohlmeyer, T. J., Pende, A., Raynolds, M. V., Sastravaha, A., Roden, R., Asano, K., Blaxall, B. C., Wu, S. C., et al. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1123 · Cited by 264
Self-citationMechanism of Action of Beta-Blocking Agents in Heart Failure
Bristow, M. R. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00846-1 · Cited by 259
Self-citationHo, D., Yan, L., Iwatsubo, K., Vatner, D. E., & Vatner, S. F. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9183-5 · Cited by 68
“Later Bristow and coworkers identified this desensitization to sympathetic stimulation as due to b-AR down regulation [6, 7].”
Background
Metadata
- Authors
- Bristow, M. R., Minobe, W. A., Raynolds, M. V., Port, J. D., Rasmussen, R., Ray, P. E., & Feldman, A. M.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-12-01
- Volume
- 92
- Issue
- 6
- Pages
- 2737-2745
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2002499022
- Cited by
- 238
- References
- 1
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.